BioStem Technologies, Inc.

BSEM Nasdaq SEC CIK 1658678
Follow BioStem Technologies Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $7.6M −27% vs same quarter last year
Net income −$11.4M −1594.7% vs same quarter last year
EPS, diluted −$0.64 −2233.3% vs same quarter last year
Operating cash flow −$8.8M −273.5% vs same quarter last year
Revenue by quarter
$11M
$10.5M
$10.1M
$7.9M
$7.6M
Q2 25 Q3 25 Q4 25 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing